NAS:ALGN (USA) Also trade in: Austria Germany UK

Align Technology Inc

$ 283.91 2.84 (1.01%)
Volume: 524,637 Avg Vol (1m): 1,012,415
Market Cap $: 22.71 Bil Enterprise Value $: 22.00 Bil
P/E (TTM): 61.32 P/B: 18.25
Earnings Power Value 44.1
Net Current Asset Value 5.71
Tangible Book 14.57
Projected FCF 54.89
Median P/S Value 151.54
Graham Number 38.96
Peter Lynch Value 115.75
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 8.6/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 13.81
Cash-To-Debt range over the past 10 years
Min: 5.57, Med: 10000, Max: 10000
Current: 13.81
5.57
10000
Equity-to-Asset 0.56
Equity-to-Asset range over the past 10 years
Min: 0.55, Med: 0.74, Max: 0.89
Current: 0.56
0.55
0.89
Debt-to-Equity 0.05
Debt-to-Equity range over the past 10 years
Min: -0.02, Med: 0.03, Max: 0.17
Current: 0.05
-0.02
0.17
Debt-to-EBITDA 0.10
Debt-to-EBITDA range over the past 10 years
Min: 0, Med: 0, Max: 0.1
Current: 0.1
0
0.1
Interest Coverage No Debt
Interest Coverage range over the past 10 years
Min: 59.51, Med: 1771.76, Max: 10000
Current: 10000
59.51
10000
Piotroski F-Score 7
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 15.97
DISTRESS
GREY
SAFE
Beneish M-Score -2.70
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 79.82%
WACC 16.34%

Profitability & Growth : 8/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 23.37
Operating Margin range over the past 10 years
Min: -10.47, Med: 23.39, Max: 27.71
Current: 23.37
-10.47
27.71
Net Margin % 18.10
Net Margin range over the past 10 years
Min: -10.01, Med: 16.37, Max: 20.35
Current: 18.1
-10.01
20.35
ROE % 31.10
ROE range over the past 10 years
Min: -12.72, Med: 19.29, Max: 33.25
Current: 31.1
-12.72
33.25
ROA % 18.97
ROA range over the past 10 years
Min: -9.86, Med: 13.99, Max: 20.86
Current: 18.97
-9.86
20.86
ROC (Joel Greenblatt) % 99.66
ROC (Joel Greenblatt) range over the past 10 years
Min: -114.37, Med: 174.76, Max: 385.53
Current: 99.66
-114.37
385.53
3-Year Total Revenue Growth Rate 32.50
3-Year Revenue Growth Rate range over the past 10 years
Min: 7.6, Med: 15.7, Max: 146.7
Current: 32.6
7.6
146.7
3-Year Total EBITDA Growth Rate 36.10
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 15.8, Max: 45.2
Current: 36.2
0
45.2
3-Year EPS w/o NRI Growth Rate 40.60
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 23.9, Max: 289.3
Current: 40.6
0
289.3

» ALGN's 30-Y Financials

Financials (Next Earnings Date: 2019-07-24)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:ALGN

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Devices » Medical Devices    NAICS : 339113    SIC : 3842
Compare NYSE:ZBH LSE:SN. SZSE:300760 XPAR:DIM NAS:ABMD ASX:COH NAS:PODD OCSE:GN SZSE:300003 NYSE:PEN NYSE:EW NAS:IART NYSE:GMED HKSE:01066 SZSE:300529 NAS:WMGI NAS:TNDM SZSE:002223 NAS:LIVN OCSE:AMBU B
Traded in other countries AFW.Germany 0HCK.UK
Address 2820 Orchard Parkway, San Jose, CA, USA, 95134
Align Technology Inc provides a clear aligner therapy system, intra-oral scanners, and computer-aided design/computer-aided manufacture digital services used in dentistry and orthodontics. The firm operates in two segments: Clear Aligner and scanners and services. The Clear Aligner segment generates the vast majority of revenue and sells the Invisalign System, which uses clear plastic removable orthodontic aligners to treat misaligned teeth. This segment also sells retainers. The scanners and services segment's key product is the iTero Scanner, an intra-oral scanner that can be used with Invisalign treatment. The iTero platform also can be used with software for restorative or orthodontic procedures. Align receives the majority of its revenue from the United States.

Ratios

Current vs industry vs history
PE Ratio (TTM) 61.32
PE Ratio range over the past 10 years
Min: 5.57, Med: 36.83, Max: 222.88
Current: 61.32
5.57
222.88
Forward PE Ratio 51.55
N/A
PE Ratio without NRI 61.32
PE without NRI range over the past 10 years
Min: 5.57, Med: 36.83, Max: 222.88
Current: 61.32
5.57
222.88
Price-to-Owner-Earnings 65.49
Price-to-Owner-Earnings range over the past 10 years
Min: 5.35, Med: 37.91, Max: 895
Current: 65.49
5.35
895
PB Ratio 18.25
PB Ratio range over the past 10 years
Min: 1.86, Med: 5.93, Max: 26.23
Current: 18.25
1.86
26.23
PS Ratio 11.07
PS Ratio range over the past 10 years
Min: 1.31, Med: 5.91, Max: 18.22
Current: 11.07
1.31
18.22
Price-to-Free-Cash-Flow 58.42
Price-to-Free-Cash-Flow range over the past 10 years
Min: 11.18, Med: 25.85, Max: 134.76
Current: 58.42
11.18
134.76
Price-to-Operating-Cash-Flow 38.68
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 8.24, Med: 21.12, Max: 67.17
Current: 38.68
8.24
67.17
EV-to-EBIT 45.26
EV-to-EBIT range over the past 10 years
Min: -71.5, Med: 23.95, Max: 97.9
Current: 45.26
-71.5
97.9
EV-to-EBITDA 39.86
EV-to-EBITDA range over the past 10 years
Min: -269.2, Med: 20.4, Max: 64.9
Current: 39.86
-269.2
64.9
EV-to-Revenue 10.58
EV-to-Revenue range over the past 10 years
Min: 0.9, Med: 5.4, Max: 17.8
Current: 10.58
0.9
17.8
PEG Ratio 2.51
PEG Ratio range over the past 10 years
Min: 1.12, Med: 2.38, Max: 5.22
Current: 2.51
1.12
5.22
Shiller PE Ratio 155.94
Shiller PE Ratio range over the past 10 years
Min: 75.36, Med: 115, Max: 680.5
Current: 155.94
75.36
680.5
Current Ratio 1.79
Current Ratio range over the past 10 years
Min: 1.59, Med: 2.85, Max: 6.96
Current: 1.79
1.59
6.96
Quick Ratio 1.70
Quick Ratio range over the past 10 years
Min: 1.55, Med: 2.77, Max: 6.82
Current: 1.7
1.55
6.82
Days Inventory 33.63
Days Inventory range over the past 10 years
Min: 9.28, Med: 30.42, Max: 33.63
Current: 33.63
9.28
33.63
Days Sales Outstanding 84.16
Days Sales Outstanding range over the past 10 years
Min: 61.69, Med: 66.49, Max: 84.16
Current: 84.16
61.69
84.16
Days Payable 41.04
Days Payable range over the past 10 years
Min: 28.34, Med: 47.12, Max: 68.75
Current: 41.04
28.34
68.75

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -0.20
3-Year Share Buyback Rate range over the past 10 years
Min: -139.2, Med: -2.6, Max: 0.5
Current: -0.2
-139.2
0.5

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 19.49
Price-to-Tangible-Book range over the past 10 years
Min: 0.91, Med: 6.69, Max: 28.2
Current: 19.49
0.91
28.2
Price-to-Projected-FCF 5.17
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 1.38, Med: 2.37, Max: 14.76
Current: 5.17
1.38
14.76
Price-to-Median-PS-Value 1.87
Price-to-Median-PS-Value range over the past 10 years
Min: 0.3, Med: 0.81, Max: 5.37
Current: 1.87
0.3
5.37
Price-to-Peter-Lynch-Fair-Value 2.45
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.57, Med: 2.27, Max: 14.72
Current: 2.45
0.57
14.72
Price-to-Graham-Number 7.29
Price-to-Graham-Number range over the past 10 years
Min: 0.86, Med: 3.37, Max: 18.27
Current: 7.29
0.86
18.27
Earnings Yield (Joel Greenblatt) % 2.22
Earnings Yield (Greenblatt) range over the past 10 years
Min: -6.2, Med: 3.9, Max: 9.1
Current: 2.22
-6.2
9.1
Forward Rate of Return (Yacktman) % 21.02
Forward Rate of Return range over the past 10 years
Min: 1, Med: 3.4, Max: 23
Current: 21.02
1
23

More Statistics

Revenue (TTM) (Mil) $ 2,078.54
EPS (TTM) $ 4.63
Beta 2.37
Volatility % 56.34
52-Week Range $ 177.93 - 398.88
Shares Outstanding (Mil) 80

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 7
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy Y
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y